Targeting the underlying inflammation in asthma triggered by white blood cells, rather than treating its symptoms, is more effective at reducing severe attacks, according to British researchers. The ...

Discovery of a novel form of cell death in eosinophils, white blood cells linked to triggering asthma, could lead to a new treatment for the disease, says respiratory physician Wen Li, director of the ...

SHR-1703 is a next-generation monoclonal antibody designed to target and reduce eosinophil white blood cells that contribute to a range of inflammatory diseases. This investigational treatment could ...